![Page 1: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/1.jpg)
Exploring the potential impact of ART in reducing HIV transmission.
Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin
Imperial College London
![Page 2: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/2.jpg)
Contents
• Potential impact of increased treatment at CD4 < 200 and < 350 on spread of infection.
• Potential impact of pre-exposure prophylaxis (PrEP).• When treatment and when PrEP?
![Page 3: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/3.jpg)
Factors decreasing the role of later stages of HIV infection and the potential of treatment to reduce
transmission
• Rapid spread and saturation of HIV in the at risk population (i.e. little ongoing spread of infection).
• Decreasing number of contacts as a function of time since infection - 1) concurrency leads to more potential contacts early infection; 2) people reducing numbers of partners over time; 3) Saturation in age cohorts
• Poor adherence; poor suppression of viral load; treatment failure and resistance.
• Slower progression to low CD4 counts.• Increased risk behaviour of those on treatment.• Increased risk behaviour amongst those not on treatment –
including susceptibles.
![Page 4: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/4.jpg)
Model - Eaton et al AIDS & Behaviour (In Press):
Transmission model (Stochastic individual based) representing generalised heterosexual epidemic – including:
• concurrency in sexual partnerships; • Heterogeneity in propensity to acquire new
partnerships; • Transmission risk within partnerships as a function of
time since infection. • Movement from high activity to moderate activity and
moderate activity to low activity over time.
Population size 50,000; seed 1% prevalence; results average of 100 runs.
![Page 5: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/5.jpg)
Transmission risk by stage of HIV infection
![Page 6: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/6.jpg)
Proportion of infections generated as a function of time since infection.
![Page 7: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/7.jpg)
Proportion of transmission by stage of infection as epidemic progresses.
![Page 8: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/8.jpg)
Population size 50,000; seed 1% prevalence; results average of 100 runs.
![Page 9: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/9.jpg)
Generalised epidemic – concurrency driving epidemic CD4< 350 after mean 4.5 years
![Page 10: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/10.jpg)
Slower progression to CD4 <350 More infections in earlier stages.Mean duration to <350 7 years.
![Page 11: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/11.jpg)
Epidemic drive by small (2%) high risk group (prevalence 1.5%) More sensitive to movement from high to low risk.
![Page 12: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/12.jpg)
PrEP model developed by Tim Hallett and Ide Cremin
The first model of PrEP for West Africa
Detailed Representation of PrEP• Detailed patterns of adherence• Targeting• Duration on PrEP
PrEP in Combination Prevention» Treatment for clinical need» Increases in condom use & reductions in numbers of partners» ‘Early’ treatment initiation
![Page 13: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/13.jpg)
The model captures many important features of HIV transmission in Cotonou:
The Mathematical Model
PrEP for prevention – preliminary results
Sex workersRegular clients
WomenMen
![Page 14: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/14.jpg)
Coverage, Adherence & Duration
PrEP for prevention – preliminary results
“Optimistic” “Realistic”
Coverage Uniform with respect to risk group and gender
Uniform with respect to risk group and gender
% of PrEP users with good adherence
80% 50%
Mean duration on PrEP
10 years 5 years
Years to reach coverage
2 years 5 years
![Page 15: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/15.jpg)
“Optimistic”
![Page 16: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/16.jpg)
“Realistic”
![Page 17: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/17.jpg)
Effective Targeting
For the same number of people staring PrEP, effective targeting to those at most risk can substantially amplify impact.
10% of population start PrEP
Good Targeting
No Targeting
Some Targeting
![Page 18: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/18.jpg)
PrEP in Combination Prevention
Status quo
Intervention to scale (incr. condom use and prompt treatment initiation)
+ Targeted effective PreP
+ The missing piece?
Numbers based on extrapolation to Urban Benin; *PreP intervention is to 60% of sex workers & clients; 70% efficacy and 80% adherence, for 10 years. ** The missing piece required to reduce incidence by 90% in 2031 and eventually stop the epidemic is a 60% efficacy vaccine delivered to half the population.
![Page 19: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/19.jpg)
Discord CD4>350 New infections0
40
80
120
Nu
mb
er
(th
ou
san
ds)
CD4>350
Discord CD4>200 New infections0
40
80
120
Nu
mb
er
(th
ou
san
ds)
CD4>200
Sexually active Susceptible Stable partner Discordant0
1000
2000
3000
4000
Nu
mb
er
(th
ou
san
ds) 52%*
13%**
91%*
![Page 20: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/20.jpg)
0 20 40 60 80 1000
5
10
15
20
25
PrEP effectiveness in couples (%)
Cu
mu
lati
ve r
isk
of
infe
ctio
n
ART initiation at CD4<350
PrEP and ART initiation at CD4<200
Domain where PrEP averts more infections that treatment in couples. Need PreP effectiveness>60%
![Page 21: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/21.jpg)
0 20 40 60 80 1000
5
10
15
20
25
PrEP effectiveness in couples (%)
Cu
mu
lati
ve r
isk
of
infe
ctio
n
PrEP and ART initiation at CD4<350
ART initiation immediately
Domain where PrEP averts more infections that treatment in couples. Need PreP effectiveness>85%
![Page 22: Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London](https://reader030.vdocuments.site/reader030/viewer/2022032415/56649f095503460f94c1dd2a/html5/thumbnails/22.jpg)
Conclusions
• Good coverage of those with CD4 < 200 could avert around 25% of new infections and with CD4 < 350 a further 15% could be averted.
• Reductions in risk behaviour associated with treatment could improve this; increases in risk behaviour could undermine it.
• PrEP can reduce incidence but needs high efficacy, coverage and adherence - and needs appropriate targeting to be efficient.
• Earlier treatment reduces role of PrEP; its effectiveness per partnership relative to treatment of the infected partner determines how useful it would be in discordant couples.